Assessing proarrhythmic potential of drugs when optimal studies are infeasible.
Rock EP, Finkle J, Fingert HJ, Booth BP, Garnett CE, Grant S, Justice RL, Kovacs RJ, Kowey PR, Rodriguez I, Sanhai WR, Strnadova C, Targum SL, Tsong Y, Uhl K, Stockbridge N.
Rock EP, et al. Among authors: fingert hj.
Am Heart J. 2009 May;157(5):827-36, 836.e1. doi: 10.1016/j.ahj.2009.02.020.
Am Heart J. 2009.
PMID: 19376308
Review.